COMP <GO>
EQIX vs BRK-B // 10Y YIELD & FRED MACRO BETA
Equinix Inc. (NASDAQ) VS. Berkshire Hathaway Inc. (Class B) (NYSE) • 15-METRIC TALLY: EQIX 5
— BRK-B 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: EQIX
LAST: $1,036.67 (+2.88%) • MKT CAP: $102.62B
macro-sensitivity
0.91
LAST: $541.96 (+0.30%) • MKT CAP: $1.20T
macro-sensitivity
0.61
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EQIX VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EQIX | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.30% | 11.47% | -5.17 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | 50.8x | 9.7x | +41.12 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 3.41% | 2.09% | +1.32 | EQIX | /fcf-yield <GO> |
| Operating Margin | 20.00% | 27.80% | -7.80 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 14.60% | 22.30% | -7.70 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 5.40% | 3.93% | +1.47 | EQIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.81% | 0.00% | +1.81 | EQIX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | EQIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 3.55% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.7 | 67.7 | -11.00 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.91 | 0.61 | +0.30 | EQIX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 70.7x | 24.3x | +46.36 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $102.62B | $1.20T | -$1.09T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EQIX REV | BRK-B REV | EQIX GROSS % | BRK-B GROSS % | EQIX FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.22B | $371.44B | 51.1% | — | $3.50B | $25.04B |
| FY 2024 | $8.75B | $371.43B | 48.9% | — | $2.86B | $11.62B |
| FY 2023 | $8.19B | $364.48B | — | — | $2.85B | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EQIX // BETA 0.91
BRK-B // BETA 0.61